Get the Stockscreener App
18.05
3.19%
0.545
Inmode Ltd stock is traded at $18.05, with a volume of 495.14K.
It is up +3.19% in the last 24 hours and up +6.16% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
See More
Previous Close:
$17.50
Open:
$17.62
24h Volume:
495.14K
Relative Volume:
0.54
Market Cap:
$1.37B
Revenue:
$492.05M
Net Income/Loss:
$197.92M
P/E Ratio:
7.8457
EPS:
2.3
Net Cash Flow:
$176.12M
1W Performance:
+3.72%
1M Performance:
+6.16%
6M Performance:
+9.51%
1Y Performance:
-23.29%
1-Day Range:
$17.51
$18.16
1-Week Range:
$16.31
$18.16
52-Week Range:
$14.87
$26.80
Inmode Ltd Stock (INMD) Company Profile
Compare INMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
18.05 | 1.37B | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
131.12 | 224.03B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.33 | 156.16B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.12 | 149.59B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.36 | 117.19B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.98 | 42.40B | 6.60B | 4.16B | 490.10M | 6.93 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
InMode Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
InMode Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
InMode: Q4 Earnings Snapshot - The Washington Post
InMode Reports Fourth Quarter and Full Year 2024 Financial Resul - GuruFocus.com
InMode earnings missed by $0.17, revenue fell short of estimates - Investing.com India
Inmode Reports Q4 And FY 2024 Results; Board Approves New Share Repurchase Program - Marketscreener.com
InMode Reports Decrease in 2024 Revenues, Announces New Share Repurchase Program - TipRanks
Earnings Flash (INMD) INMODE LTD. Posts Q4 Adjusted EPS $0.42, vs. FactSet Est of $0.53 - Marketscreener.com
InMode: Q4 Earnings Snapshot -February 04, 2025 at 07:17 am EST - Marketscreener.com
InMode reports revenue dip, plans share repurchase - Investing.com
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program - PR Newswire
InMode (INMD) to Release Quarterly Earnings on Tuesday - MarketBeat
InMode Ltd. (NASDAQ:INMD) Shares Sold by Boston Trust Walden Corp - MarketBeat
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference - StreetInsider.com
InMode Ltd. (NASDAQ:INMD) Stake Cut by SG Americas Securities LLC - MarketBeat
[Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
InMode Ltd. (NASDAQ:INMD) Receives $22.40 Consensus Target Price from Brokerages - MarketBeat
Do Options Traders Know Something About InMode (INMD) Stock We Don't? - Yahoo Finance
InMode: A Clear Bargain With Unique Risks (NASDAQ:INMD) - Seeking Alpha
Inmode Ltd to Host Earnings Call - ACCESS Newswire
Objective long/short (INMD) Report - Stock Traders Daily
InMode (NASDAQ:INMD) earnings and shareholder returns have been trending downwards for the last three years, but the stock rallies 5.1% this past week - Yahoo Finance
INMDInMode Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced - Nasdaq
DOMA Perpetual urges InMode for immediate tender offer By Investing.com - Investing.com Australia
DOMA Perpetual urges InMode for immediate tender offer - Investing.com
InMode Shareholder Demands 30% Tender Offer, Slams Board Over $640M Cash Hoarding - StockTitan
InMode Enters Oversold Territory (INMD) - Nasdaq
Barclays Has Lowered Expectations for InMode (NASDAQ:INMD) Stock Price - Defense World
InMode: Clearly, I Was Too Optimistic (Rating Downgrade) - Seeking Alpha
JPMorgan Chase & Co. Sells 145,448 Shares of InMode Ltd. (NASDAQ:INMD) - MarketBeat
Needham reiterates Hold on InMode shares amid revenue miss By Investing.com - Investing.com Australia
InMode (NASDAQ:INMD) Price Target Cut to $26.00 by Analysts at Barclays - MarketBeat
Canaccord keeps InMode stock hold rating, $17 price target By Investing.com - Investing.com Nigeria
Canaccord keeps InMode stock hold rating, $17 price target - Investing.com India
Needham reiterates Hold on InMode shares amid revenue miss - Investing.com India
Needham maintains Hold on InMode shares amid revenue miss - Investing.com India
InMode estimates Q4 revenue below consensus - MSN
InMode (NASDAQ:INMD) Shares Gap DownHere's What Happened - MarketBeat
Needham maintains Hold on InMode shares amid revenue miss By Investing.com - Investing.com Canada
InMode to Report Fourth Quarter & Full Year 2024 Financial Resul - GuruFocus.com
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.30%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):